After search, choose a molecule or a kind of categories listed in the left to narrow down your filter. If you have any problems, please contact us!
Text Size:AAA

TRAIL R2 / CD262 / TNFRSF10B Antibody, Rabbit MAb

DatasheetReviewsRelated ProductsProtocols
Human TRAILR2 Antibody Product Information
Immunogen:Recombinant Human CD262 protein (Catalog#10465-H08H)
Clone ID:102
Ig Type:Rabbit IgG
Formulation:0.2 μm filtered solution in PBS with 5% trehalose
Preparation:This antibody was obtained from a rabbit immunized with purified, recombinant Human TNFRSF10B / CD262 extracellular domain (rh TNFRSF10B; Catalog#10465-H08H; Met 1-Glu 182; NP_003833.3).
Human TRAILR2 Antibody Usage Guide
Specificity:Human TNFRSF10B / TRAILR2 / CD262 / DR5
No cross-reactivity in ELISA with
Human TNFRSF10A / CD261 / APO2
Human TNFRSF10D / CD264 / DCR2 / TRAILR4
Application:ELISA, FCM

ELISA: 0.1-0.2 μg/mL

This antibody can be used at 0.1-0.2 μg/mL with the appropriate secondary reagents to detect Human TNFRSF10B. The detection limit for Human TNFRSF10B is 0.00245 ng/well.

FCM: 0.5-2 μg/Test

Storage:This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free.
Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.
Human TRAILR2 Antibody FC Application Image
TRAIL R2 / CD262 / TNFRSF10B Antibody, Rabbit MAb, Flow cytometric analysis
[Click to enlarge image]
Flow cytometric analysis of Human TNFRSF10B(CD262) expression on Jurkat cells. Cells were stained with purified anti-Human TNFRSF10B(CD262), then a FITC-conjugated second step antibody. The histogram were derived from gated events with the forward and side light-scatter characteristics of intact cells.
Other TRAILR2 Antibody Products
TRAIL R2/CD262/TNFRSF10B Background

Tumor necrosis factor receptor superfamily, member 10b, official symbol TNFRSF10B, also known as Death receptor 5, CD262, TNF-related apoptosis-inducing ligand receptor 2 (TRAIL R2), is a member of the TNF-receptor superfamily, and contains an intracellular death domain. This receptor can be activated by tumor necrosis factor-related apoptosis inducing ligand (TNFSF10/TRAIL/APO-2L), and transduces an apoptosis signal. Studies with FADD-deficient mice suggested that FADD, a death domain containing adaptor protein, is required for the apoptosis mediated by this protein. TRAIL R2/CD262/TNFRSF10B was purified independently as the only receptor for TRAIL detectable on the surface of two different human cell lines that undergo apoptosis upon stimulation with TRAIL. TRAIL R2/CD262/TNFRSF10B contains two extracellular cysteine-rich repeats, typical for TNF receptor (TNFR) family members, and a cytoplasmic death domain. TRAIL R2/CD262/TNFRSF10B mediates apoptosis via the intracellular adaptor molecule FADD/MORT1. TRAIL receptors can signal both death and gene transcription, functions reminiscent of those of TNFR1 and TRAMP, two other members of the death receptor family. Defects in TRAIL R2/CD262/TNFRSF10B may be a cause of head and neck squamous cell carcinomas (HNSCC) also known as squamous cell carcinoma of the head and neck.

Human TRAIL R2/CD262/TNFRSF10B References
  • Schneider P, et al. (1997) TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. Immunity. 7(6): 831-6.
  • Ichikawa K, et al. (2003) TRAIL-R2 (DR5) mediates apoptosis of synovial fibroblasts in rheumatoid arthritis. J Immunol. 171(2): 1061-9.
  • Walczak H, et al. (1997) TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J. 16(17): 5386-97.
  • Product nameProduct name
    Size / Price
    Catalog: 10465-R102-50
    List Price: 
    Price:      (You Save: )
    50 µg
    100 µg
    AvailabilityIn Stock
    Bulk Discount InquiryAdd to Cart
    All information of our products is subject to change without notice. Please refer to COA enclosed in shipped package for the newest information.